ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

BGNE BeiGene Ltd

160,56
-1,92 (-1,18%)
08 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
BeiGene Ltd BGNE NASDAQ Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
-1,92 -1,18% 160,56 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
162,99 158,21 164,40 160,56 162,48
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/4/202416:34BWBeiGene Demonstrates Global Progress in 2023 Responsible..
25/4/202413:11BWGlobaler Onkologie-Innovator BeiGene präsentiert auf der..
25/4/202413:10BWBeiGene, innovateur mondial en oncologie, présente de..
24/4/202422:01BWGlobal Oncology Innovator BeiGene Highlights New Data across..
24/4/202401:31BWBeiGene reçoit l’approbation de la Commission européenne..
23/4/202412:00BWBeiGene Receives European Commission Approval for..
16/3/202416:18BWBeiGene、化学療法後の進行性または転移性食道扁平上皮癌の治療のためのTEVIMBRA®のFDA承認取得
15/3/202422:13BW百濟神州喜獲FDA批准,TEVIMBRA®將用於晚期或轉移性食管鱗狀細胞癌在化療後的治療
15/3/202421:02BWBeiGene reçoit l'approbation de la FDA pour TEVIMBRA® dans..
15/3/202407:06BWBeiGene erhält FDA-Zulassung für TEVIMBRA ® zur Behandlung..
14/3/202421:28BWBeiGene Receives FDA Approval for TEVIMBRA® for the..
14/3/202415:23BWマックス財団、ベイジーン、ベイジーン財団の協力により、低・中所得国の慢性リンパ性白血病患者にBRUKINSA®を初回投与
14/3/202410:31BWThe Max Foundation、BeiGene和BeiGene..
13/3/202420:01BWErste Dosen von BRUKINSA ® für Patienten mit chronischer..
13/3/202413:00BWFirst Doses of BRUKINSA® provided to Patients with Chronic..
07/3/202423:19BWBeiGene Announces FDA Accelerated Approval of BRUKINSA for..
06/3/202412:00BWBeiGene to Present Clinical and Preclinical Data from Broad..
29/2/202417:17BWベイジーン、2023年第4・四半期および通期決算と事業に関する最新情報を発表
29/2/202416:00BWBeiGene Announces New Efficacy Analysis Comparing BRUKINSA®..
29/2/202401:56BWBeiGene publie ses résultats financiers du quatrième..
28/2/202419:13BWBeiGene meldet Finanzergebnisse für das vierte Quartal und..
28/2/202414:05BWBeiGene to Present at Upcoming Investor Conferences
28/2/202413:43BWベイジーン、非小細胞肺がん治療薬チスレリズマブに対してCHMPから肯定的意見を受領
28/2/202412:48BWBeiGene公布2023年第四季及全年財務業績和最新業務情況
27/2/202413:24BW百濟神州(BeiGene)獲得 CHMP 對替雷利珠單抗(Tislelizumab)治療非小細胞肺癌的積極意見
27/2/202413:22BWBeiGene erhält positives CHMP-Gutachten für Tislelizumab zur..
27/2/202412:00BWBeiGene’s Biologics License Application for TEVIMBRA®..
26/2/202412:02EDGAR2Form 8-K - Current report
26/2/202412:00BWBeiGene Reports Fourth Quarter and Full Year 2023 Financial..
26/2/202411:00BWBeiGene Receives Positive CHMP Opinion for Tislelizumab as..
07/2/202412:47PRNCAHealth Canada Approves BRUKINSA® (zanubrutinib) for the..
31/1/202412:47PRNCAAdults living with chronic lymphocytic leukemia (CLL) in..
24/1/202420:03BWベイジーン、取締役会に経験豊富なライフサイエンス界のエグゼクティブ、オリビエ・ブランディクールを迎える
23/1/202418:04BWBeiGene accueille au sein de son conseil d'administration,..
23/1/202417:55BWBeiGene heißt den erfahrenen Life Sciences Manager Olivier..
23/1/202412:03EDGAR2Form 8-K - Current report
23/1/202412:00BWBeiGene Welcomes Experienced Life Sciences Executive Olivier..
22/12/202312:00BWFDA Approves Label Update for BRUKINSA® (zanubrutinib) in..
21/12/202312:01BWBeiGene to Present at the 42nd Annual J.P. Morgan Healthcare..
29/11/202322:01BWBeiGene to Host ASH Investor Meeting in Person and via..
28/11/202312:00BWBeiGene to Present New Data Highlighting Hematology..
21/11/202312:00BWBeiGene and Ensem Therapeutics Announce Partnership to..
17/11/202312:00BWBeiGene Receives European Commission Approval for BRUKINSA®..
09/11/202322:08EDGAR2Form 8-K - Current report
09/11/202322:01BWBeiGene Continues Global Growth with Third Quarter 2023..
08/11/202312:00BWBeiGene to Present at the Jefferies London Healthcare..
20/10/202322:04EDGAR2Form 8-K - Current report
20/10/202312:00BWBRUKINSA® Receives Positive Recommendation from NICE in U.K...
17/10/202322:01BWBeiGene Announces the Phase 3 RATIONALE 315 Trial Met..
16/10/202312:00BWBeiGene Presentations at ESMO 2023 Demonstrate Robust..

Dernières Valeurs Consultées

Delayed Upgrade Clock